federal enforcement actions, filings and court records, from official sources

••• ⚠️ Newsticker presented by CFExclusion.com ⚠️ ••• 🚨 FRAUD WATCH — Federal authorities announced charges against 16 noncitizens in alleged election-related crimes, including illegal voting and fraudulent voter registration; defendants remain presumed innocent.  • 🤖 AI SECURITY — Researchers report autonomous AI agents attempting hacking techniques against government websites, while malicious AI tools are increasingly being used in cyberattacks.  • 💻 ONLINE THEFT — The FBI says multiple suspects have been arrested in the ShinyHunters data-theft investigation following attacks involving stolen information and extortion.  • 🇺🇸 TRUMP — Trump announced a federal “Super Intelligence Force” to coordinate America’s AI strategy and maintain U.S. technological leadership.  • 🏛️ POLITICS — With one month until the midterms, control of Congress is tightening into a major national battle.  • 🔎 AI SCREENING — As fraud, stolen identities and automated attacks accelerate, AI-based scre

Records through Monday, October 12, 2026 DOJ · SEC · FTC · FDA · CFPB · CFTC · FINRA · OCC · Federal Register · CourtListener · SCOTUSblog

U.S. Food and Drug Administration · FDA enforcement report entry

FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for:

The U.S. Food and Drug Administration listed this entry in its enforcement reports on September 2, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.

Read the official source on fda.gov →

Issued by: U.S. Food and Drug Administration
Document type: FDA enforcement report entry
Date: September 2, 2026
First recorded by CourtPulse: September 8, 2026 · all records that day
Category: FDA action (assigned by CourtPulse)

CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.

More from U.S. Food and Drug Administration, within 7 days

FDA Class II: Apotex Corp. — Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: A Sep 2, 2026 · FDA enforcement report entry
FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for Sep 2, 2026 · FDA enforcement report entry
FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451- Sep 2, 2026 · FDA enforcement report entry
FDA Class I: B BRAUN MEDICAL INC — Lactated Ringer's Injection USP, 1000 mL EXCEL container, Rx only, L7500, B. Braun Medical, Inc., Be Sep 2, 2026 · FDA enforcement report entry
FDA Class I: Fresenius Kabi USA, LLC — Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL (20 mg/mL), 20 mL vial, Rx Only, Manufactured by Sep 2, 2026 · FDA enforcement report entry
FDA Class II: ACCORD HEALTHCARE, INC. — Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45 Sep 2, 2026 · FDA enforcement report entry

Get records like this one daily by email →